FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136280619> ?p ?o ?g. }

• W2136280619 endingPage "571" @default.
• W2136280619 startingPage "562" @default.
• W2136280619 abstract "The free-radical-trapping agent NXY-059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing disability when given to patients who had acute ischemic stroke. We sought confirmation of efficacy in a second, larger trial.We enrolled 3306 patients with acute ischemic stroke in a randomized, double-blind trial to receive a 72-hour infusion of intravenous NXY-059 or placebo within 6 hours after the onset of stroke symptoms. Our primary end point was the distribution of disability scores on the modified Rankin scale at 90 days. We examined scores on neurologic and activities-of-daily-living scales as secondary end points. We also tested the hypothesis that NXY-059 would reduce alteplase-related intracranial hemorrhages.The efficacy analysis was based on 3195 patients. Prognostic factors were well balanced between the treatment groups. Mortality was equal in the two groups, and adverse-event rates were similar. The distribution of scores on the modified Rankin scale did not differ between the group treated with NXY-059 (1588 patients) and the placebo group (1607 patients; P=0.33 by the Cochran-Mantel-Haenszel test; odds ratio for limiting disability, 0.94; 95% confidence interval [CI], 0.83 to 1.06). Analysis of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 versus 2 to 3 versus 4 to 6 was 0.92 (95% CI, 0.80 to 1.06). There was no evidence of efficacy for any of the secondary end points. Among patients treated with alteplase, there was no difference between the NXY-059 group and the placebo group in the frequency of symptomatic or asymptomatic hemorrhage.NXY-059 is ineffective for the treatment of acute ischemic stroke within 6 hours after the onset of symptoms. (ClinicalTrials.gov number, NCT00061022 [ClinicalTrials.gov].)" @default.
• W2136280619 created "2016-06-24" @default.
• W2136280619 creator A5002719602 @default.
• W2136280619 creator A5003407929 @default.
• W2136280619 creator A5026886390 @default.
• W2136280619 creator A5033104412 @default.
• W2136280619 creator A5039358787 @default.
• W2136280619 creator A5041751659 @default.
• W2136280619 creator A5050507154 @default.
• W2136280619 creator A5064086551 @default.
• W2136280619 creator A5079574532 @default.
• W2136280619 creator A5086474167 @default.
• W2136280619 date "2007-08-09" @default.
• W2136280619 modified "2023-10-16" @default.
• W2136280619 title "NXY-059 for the Treatment of Acute Ischemic Stroke" @default.
• W2136280619 cites W1550111394 @default.
• W2136280619 cites W1848977294 @default.
• W2136280619 cites W1964656269 @default.
• W2136280619 cites W1969661146 @default.
• W2136280619 cites W1992877627 @default.
• W2136280619 cites W2068121825 @default.
• W2136280619 cites W2074463413 @default.
• W2136280619 cites W2080504768 @default.
• W2136280619 cites W2112646710 @default.
• W2136280619 cites W2135637406 @default.
• W2136280619 cites W2137545445 @default.
• W2136280619 cites W2157368934 @default.
• W2136280619 cites W2188223674 @default.
• W2136280619 doi "https://doi.org/10.1056/nejmoa070240" @default.
• W2136280619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17687131" @default.
• W2136280619 hasPublicationYear "2007" @default.
• W2136280619 type Work @default.
• W2136280619 sameAs 2136280619 @default.
• W2136280619 citedByCount "655" @default.
• W2136280619 countsByYear W21362806192012 @default.
• W2136280619 countsByYear W21362806192013 @default.
• W2136280619 countsByYear W21362806192014 @default.
• W2136280619 countsByYear W21362806192015 @default.
• W2136280619 countsByYear W21362806192016 @default.
• W2136280619 countsByYear W21362806192017 @default.
• W2136280619 countsByYear W21362806192018 @default.
• W2136280619 countsByYear W21362806192019 @default.
• W2136280619 countsByYear W21362806192020 @default.
• W2136280619 countsByYear W21362806192021 @default.
• W2136280619 countsByYear W21362806192022 @default.
• W2136280619 countsByYear W21362806192023 @default.
• W2136280619 crossrefType "journal-article" @default.
• W2136280619 hasAuthorship W2136280619A5002719602 @default.
• W2136280619 hasAuthorship W2136280619A5003407929 @default.
• W2136280619 hasAuthorship W2136280619A5026886390 @default.
• W2136280619 hasAuthorship W2136280619A5033104412 @default.
• W2136280619 hasAuthorship W2136280619A5039358787 @default.
• W2136280619 hasAuthorship W2136280619A5041751659 @default.
• W2136280619 hasAuthorship W2136280619A5050507154 @default.
• W2136280619 hasAuthorship W2136280619A5064086551 @default.
• W2136280619 hasAuthorship W2136280619A5079574532 @default.
• W2136280619 hasAuthorship W2136280619A5086474167 @default.
• W2136280619 hasBestOaLocation W21362806191 @default.
• W2136280619 hasConcept C126322002 @default.
• W2136280619 hasConcept C127413603 @default.
• W2136280619 hasConcept C142724271 @default.
• W2136280619 hasConcept C156957248 @default.
• W2136280619 hasConcept C168563851 @default.
• W2136280619 hasConcept C203092338 @default.
• W2136280619 hasConcept C204787440 @default.
• W2136280619 hasConcept C27081682 @default.
• W2136280619 hasConcept C2780645631 @default.
• W2136280619 hasConcept C2780931571 @default.
• W2136280619 hasConcept C3020199598 @default.
• W2136280619 hasConcept C42219234 @default.
• W2136280619 hasConcept C44249647 @default.
• W2136280619 hasConcept C541997718 @default.
• W2136280619 hasConcept C71924100 @default.
• W2136280619 hasConcept C78519656 @default.
• W2136280619 hasConceptScore W2136280619C126322002 @default.
• W2136280619 hasConceptScore W2136280619C127413603 @default.
• W2136280619 hasConceptScore W2136280619C142724271 @default.
• W2136280619 hasConceptScore W2136280619C156957248 @default.
• W2136280619 hasConceptScore W2136280619C168563851 @default.
• W2136280619 hasConceptScore W2136280619C203092338 @default.
• W2136280619 hasConceptScore W2136280619C204787440 @default.
• W2136280619 hasConceptScore W2136280619C27081682 @default.
• W2136280619 hasConceptScore W2136280619C2780645631 @default.
• W2136280619 hasConceptScore W2136280619C2780931571 @default.
• W2136280619 hasConceptScore W2136280619C3020199598 @default.
• W2136280619 hasConceptScore W2136280619C42219234 @default.
• W2136280619 hasConceptScore W2136280619C44249647 @default.
• W2136280619 hasConceptScore W2136280619C541997718 @default.
• W2136280619 hasConceptScore W2136280619C71924100 @default.
• W2136280619 hasConceptScore W2136280619C78519656 @default.
• W2136280619 hasIssue "6" @default.
• W2136280619 hasLocation W21362806191 @default.
• W2136280619 hasLocation W21362806192 @default.
• W2136280619 hasOpenAccess W2136280619 @default.
• W2136280619 hasPrimaryLocation W21362806191 @default.
• W2136280619 hasRelatedWork W1974032428 @default.
• W2136280619 hasRelatedWork W1994858555 @default.
• W2136280619 hasRelatedWork W2122595195 @default.

• next